{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:57:26Z","timestamp":1792411046502,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81616-3","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T16:08:10Z","timestamp":1736525290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Xen 63 versus Preserflo MicroShunt implant in patients with primary open-angle glaucoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Mart\u00ednez-de-la-Casa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pascual-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morales-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Saez-Frances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Garcia-Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Guemes-Villahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Sanchez-Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Garcia-Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"81616_CR1","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","volume":"2","author":"RN Weinreb","year":"2016","unstructured":"Weinreb, R. N. et al. Primary open-angle glaucoma. Nat. Rev. Dis. Primers. 2, 16067 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"81616_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl, A. et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest Glaucoma trial. Arch. Ophthalmol. 120(10), 1268\u20131279 (2002).","journal-title":"Arch. Ophthalmol."},{"issue":"1 Suppl","key":"81616_CR3","first-page":"S20","volume":"14","author":"SJ McKinnon","year":"2008","unstructured":"McKinnon, S. J., Goldberg, L. D., Peeples, P., Walt, J. G. & Bramley, T. J. Current management of glaucoma and the need for complete therapy. Am. J. Manag Care. 14(1 Suppl), S20\u2013S27 (2008).","journal-title":"Am. J. Manag Care"},{"key":"81616_CR4","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma. ;105:1-169.5th Edition. Azuara Blanco A., Traverso C.E. (Eds); British Journal of Ophthalmology (2021).","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"issue":"11","key":"81616_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter, P. R. et al. Interim clinical outcomes in the collaborative initial Glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108(11), 1943\u20131953 (2001).","journal-title":"Ophthalmology"},{"issue":"7","key":"81616_CR6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey, P. A. et al. The most common barriers to Glaucoma medication adherence: a cross-sectional survey. Ophthalmology 122(7), 1308\u20131316 (2015).","journal-title":"Ophthalmology"},{"issue":"4","key":"81616_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers, J., Martin, K., Sarkies, N., Bourne, R. & Watson, P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119(4), 694\u2013702 (2012).","journal-title":"Ophthalmology"},{"issue":"1","key":"81616_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","volume":"140","author":"HD Jampel","year":"2005","unstructured":"Jampel, H. D. et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am. J. Ophthalmol. 140(1), 16\u201322 (2005).","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"81616_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/03007995.2024.2322048","volume":"40","author":"MF Cordeiro","year":"2024","unstructured":"Cordeiro, M. F. et al. Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma. Curr. Med. Res. Opin. 40(4), 647\u2013655 (2024).","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"81616_CR10","doi-asserted-by":"publisher","first-page":"e0024","DOI":"10.5041\/RMMJ.10345","volume":"9","author":"L Bar-David","year":"2018","unstructured":"Bar-David, L. & Blumenthal, E. Z. Evolution of Glaucoma surgery in the last 25 years. Rambam Maimonides Med. J. 9(3), e0024 (2018).","journal-title":"Rambam Maimonides Med. J."},{"issue":"Suppl 1","key":"81616_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","volume":"107","author":"L Abegao Pinto","year":"2023","unstructured":"Abegao Pinto, L. et al. EGS surgery taskforce. European Glaucoma Society - A guide on surgical innovation for glaucoma. Br. J. Ophthalmol. 107(Suppl 1), 1\u2013114 (2023).","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"81616_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ogla.2023.05.001","volume":"6","author":"IM Hussein","year":"2023","unstructured":"Hussein, I. M., De Francesco, T. & Ahmed, I. I. K. Intermediate outcomes of the Novel 63-\u00b5m gelatin microstent versus the conventional 45-\u00b5m gelatin microstent. Ophthalmol. Glaucoma. 6(6), 580\u2013591 (2023).","journal-title":"Ophthalmol. Glaucoma"},{"issue":"8","key":"81616_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/jcm10081628","volume":"10","author":"AM Fea","year":"2021","unstructured":"Fea, A. M. et al. Early experience with the New Xen63 Implant in Primary Open-Angle Glaucoma patients: clinical outcomes. J. Clin. Med. 10(8), 1628 (2021).","journal-title":"J. Clin. Med."},{"issue":"13","key":"81616_CR14","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3390\/jcm11133801","volume":"11","author":"AM Fea","year":"2022","unstructured":"Fea, A. M. et al. Outcomes of Xen 63 device at 18-Month Follow-Up in Glaucoma patients: a two-Center Retrospective Study. J. Clin. Med. 11(13), 3801 (2022).","journal-title":"J. Clin. Med."},{"issue":"15","key":"81616_CR15","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.3390\/jcm12155043","volume":"12","author":"C Evers","year":"2023","unstructured":"Evers, C. et al. Xen-63 compared to Xen-45 gel stents to reduce intraocular pressure in Glaucoma. J. Clin. Med. 12(15), 5043 (2023).","journal-title":"J. Clin. Med."},{"issue":"1","key":"81616_CR16","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41598-024-55287-z","volume":"14","author":"JM Mart\u00ednez-de-la-Casa","year":"2024","unstructured":"Mart\u00ednez-de-la-Casa, J. M. et al. Effectiveness and safety of Xen63 in patients with primary-open-angle glaucoma. Sci. Rep. 14(1), 4561. https:\/\/doi.org\/10.1038\/s41598-024-55287-z (2024).","journal-title":"Sci. Rep."},{"issue":"8","key":"81616_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jcrs.2014.01.032","volume":"40","author":"RA Lewis","year":"2014","unstructured":"Lewis, R. A. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J. Cataract Refract. Surg. 40(8), 1301\u20131306 (2014).","journal-title":"J. Cataract Refract. Surg."},{"issue":"10","key":"81616_CR18","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00417-021-05188-y","volume":"259","author":"FA Aghayeva","year":"2021","unstructured":"Aghayeva, F. A., Chronopoulos, P., Schuster, A. K., Pfeiffer, N. & Hoffmann, E. M. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo microshunt implantation. Graefes Arch. Clin. Exp. Ophthalmol. 259(10), 3045\u20133053 (2021).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"81616_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers, H. J. M. et al. Safety and Effectiveness of the Preserflo MicroShunt in Primary Open-Angle Glaucoma: results from a 2-Year Multicenter Study. Ophthalmol. Glaucoma. 5(2), 195\u2013209 (2022).","journal-title":"Ophthalmol. Glaucoma"},{"issue":"4","key":"81616_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","volume":"37","author":"R Bhayani","year":"2023","unstructured":"Bhayani, R. et al. Short-term safety and efficacy of Preserflo Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond). 37(4), 644\u2013649 (2023).","journal-title":"Eye (Lond)"},{"issue":"3","key":"81616_CR21","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat, K. R. et al. Preserflo MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 100(3), e779\u2013e790 (2022).","journal-title":"Acta Ophthalmol."},{"issue":"10","key":"81616_CR22","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","volume":"261","author":"M Jamke","year":"2023","unstructured":"Jamke, M. et al. Preserflo MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch. Clin. Exp. Ophthalmol. 261(10), 2901\u20132915 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"81616_CR23","doi-asserted-by":"publisher","first-page":"15600","DOI":"10.1038\/s41598-021-95217-x","volume":"11","author":"JM Mart\u00ednez-de-la-Casa","year":"2021","unstructured":"Mart\u00ednez-de-la-Casa, J. M. et al. Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients. Sci. Rep. 11(1), 15600 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"81616_CR24","first-page":"417","volume":"72","author":"M Rojo-Arnao","year":"2024","unstructured":"Rojo-Arnao, M. et al. Preserflo MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting. Indian J. Ophthalmol. 72(3), 417\u2013426 (2024).","journal-title":"Indian J. Ophthalmol."},{"issue":"7","key":"81616_CR25","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/IJG.0000000000002419","volume":"33","author":"J Pietris","year":"2024","unstructured":"Pietris, J. & Casson, R. One-year outcomes of Preserflo Microshunt for Primary Open Angle Glaucoma: a systematic review and Meta-analysis. J. Glaucoma. 33(7), e27\u2013e34 (2024).","journal-title":"J. Glaucoma"},{"issue":"3","key":"81616_CR26","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres, L. M. J. et al. Xen Gel Stent compared to Preserflo MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 99(3), e433\u2013e440 (2021).","journal-title":"Acta Ophthalmol."},{"key":"81616_CR27","doi-asserted-by":"publisher","unstructured":"L\u00fcke, J. N. et al. Matched case-control comparison of surgical success after Xen45 gel stent and Preserflo MicroShunt implantation in a caucasian population. Clin. Exp. Ophthalmol. 6 https:\/\/doi.org\/10.1111\/ceo.14407 (2024 Jun).","DOI":"10.1111\/ceo.14407"},{"issue":"8","key":"81616_CR28","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1167\/iovs.16-19453","volume":"57","author":"TS Shute","year":"2016","unstructured":"Shute, T. S. et al. Biocompatibility of a Novel Microfistula Implant in Nonprimate mammals for the Surgical Treatment of Glaucoma. Invest. Ophthalmol. Vis. Sci. 57(8), 3594\u20133600 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"81616_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.biomaterials.2007.09.041","volume":"29","author":"L Pinchuk","year":"2008","unstructured":"Pinchuk, L. et al. Medical applications of poly(styrene-block-isobutylene-block-styrene) (SIBS). Biomaterials 29(4), 448\u2013460 (2008).","journal-title":"Biomaterials"},{"key":"81616_CR30","first-page":"1945","volume":"9","author":"A Al Habash","year":"2015","unstructured":"Al Habash, A., Aljasim, L. A., Owaidhah, O. & Edward, D. P. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin. Ophthalmol. 9, 1945\u20131951 (2015).","journal-title":"Clin. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81616-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T17:06:30Z","timestamp":1736528790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["81616"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81616-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cAll procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethic Committee of the Centro Italiano Glaucoma Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Due to the characteristics of the study, the Ethic Committee of the San Carlos Clinical Hospital waived the need for written informed consent. Any information that could lead to an individual being identified has been encrypted or removed, as appropriate, to guarantee their anonymity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1634"}}